A randomized controlled trial has shown that Metaberine significantly enhances metabolic health factors at a low dosage. The berberine ingredient, by nutraceutical company Zeus Hygia Life Sciences, improved fasting glucose levels, GLP-1 secretion, and lipid profiles compared to placebo, at a five- to seven-fold lower dose than conventional formulations.